General Gastro News Articles

Gastro

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Jensen DM et al. - High-dose intravenous esomeprazole given after successful endoscopic therapy to patients with high-risk peptic ulcer bleeding reduced recurrent bleeding at 72 hours and had sustained clinical benefits for up to 30 days.

Related Articles

Adrenaline injection plus argon plasma coagulation versus adrenaline injection plus hemoclips for treating high-risk bleeding peptic ulcers: A prospective, randomized trial
Canadian Journal of Gastroenterology, 10/12/09    Relevance Score: 81%

Preadmission use of SSRIs alone or in combination with NSAIDs and 30-day mortality after peptic ulcer bleeding
Scandinavian Journal of Gastroenterology, 11/06/09    Relevance Score: 79%

Meckels Diverticulum Diagnosed by Double-Balloon Enteroscopy in an Adult Presenting With Obscure Gastrointestinal Bleeding
Clinical Gastroenterology and Hepatology, 11/05/09    Relevance Score: 78%

Uncomplicated peptic ulcer in the UK: trends from 1997 to 2005
Alimentary Pharmacology and Therapeutics, 10/23/09    Relevance Score: 69%

Comparison of Hemostatic Efficacy for Argon Plasma Coagulation and Distilled Water Injection in Treating High-risk Bleeding Ulcers
Journal of Clinical Gastroenterology, 10/21/09    Relevance Score: 68%

Today in GI Bleeding...keeping you current

Factors Associated with the Clinical Impact of Capsule Endoscopy in Patients with Overt Obscure Gastrointestinal Bleeding
Digestive Diseases and Sciences, 12/10/09

Rectal Inflammatory Polyp in a Child: An Unusual Case of Polyparasitism
Journal of Tropical Pediatrics, 12/10/09

Anastomotic leakage after anterior resection for rectal cancer: risk factors
Colorectal Disease, 12/10/09

Today in Pharmacology/kinetics...keeping you current

Chemoprevention in Barrett's Esophagus: Are We There Yet, Are We There Yet...
Clinical Gastroenterology and Hepatology , 12/10/09

Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update
Clinical and Experimental Gastroenterology, 12/10/09

Long-Term Tegaserod Treatment for Dysmotility-like Functional Dyspepsia: Results of Two Identical 1-year Cohort Studies
Digestive Diseases and Sciences, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address